|0.4969 0.018 (3.74%)||12-07 15:58|
|Targets||6-month :||0.58||1-year :||0.68|
|Resists||First :||0.5||Second :||0.58|
|Supports||First :||0.42||Second :||0.37|
|MAs||MA(5) :||0.47||MA(20) :||0.44|
|MA(100) :||0.62||MA(250) :||0.94|
|MACD||MACD :||0||Signal :||-0.1|
|%K %D||K(14,3) :||81.9||D(3) :||77.4|
|52-week||High :||2.03||Low :||0.37|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ STSS ] has closed below upper band by 13.8%. Bollinger Bands are 55.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||0.5 - 0.5||0.5 - 0.5|
|Low:||0.48 - 0.48||0.48 - 0.48|
|Close:||0.48 - 0.48||0.48 - 0.48|
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Medical Instruments & Supplies
|Shares Out||15 (M)|
|Shares Float||11 (M)|
|Held by Insiders||23.7 (%)|
|Held by Institutions||4.1 (%)|
|Shares Short||182 (K)|
|Shares Short P.Month||184 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||0.68|
|Profit Margin||0 %|
|Operating Margin||0 %|
|Return on Assets (ttm)||-45 %|
|Return on Equity (ttm)||-74.8 %|
|Qtrly Rev. Growth||0 %|
|Gross Profit (p.s.)||0|
|Sales Per Share||0|
|Qtrly Earnings Growth||0 %|
|Operating Cash Flow||-8 (M)|
|Levered Free Cash Flow||-8 (M)|
|Price to Book value||0.69|
|Price to Sales||0|
|Price to Cash Flow||-0.9|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|